Kirkland & Ellis advised THL Partners on the transaction, and Paul Weiss Rifkind Wharton & Garrison advised THL Partners on the debt financing aspects. THL Partners,...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer is advising Sanofi, while Kirkland & Ellis and Debevoise & Plimpton are advising CD&R on the transaction. French drugmaker Sanofi and Clayton Dubilier...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Cleary Gottlieb Steen & Hamilton represented GTCR in the transaction, and Faegre Drinker Biddle & Reath represented Surmodics. GTCR, a leading private...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Ingersoll Rand Inc. on the transaction, and Simpson Thacher & Bartlett advised ILC Dover and New Mountain Capital. Ingersoll Rand Inc. (NYSE:IR),...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
You must be a Standard 1 Year member to access this content.
